Evidence map›Paper›PMID 28899522›Full record

Trial reportSleep medicine2017

Actigraphy scoring for sleep outcome measures in chronic obstructive pulmonary disease.

Mary C Kapella, Sachin Vispute, Bingqian Zhu, James J Herdegen

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Sleep medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Evening blue-light exposure, maternal glucose, and infant birthweight.Annals of the New York Academy of Sciences · 2022
    Article
  7. Article
  8. Evaluation of the Vibe Actigraph in Patients With Chronic Obstructive Pulmonary Disease: A Pilot Study.IEEE journal of translational engineering in health and medicine · 2020
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mary C KapellaUniversity of Illinois at Chicago, Center for Narcolepsy, Sleep and Health Research, Department of Biobehavioral Health Science, College of Nursing, USA. Electronic address: mkapel1@uic.edu.
Sachin VisputeUniversity of Illinois at Chicago, Center for Narcolepsy, Sleep and Health Research, Department of Biobehavioral Health Science, College of Nursing, USA.
Bingqian ZhuUniversity of Illinois at Chicago, Center for Narcolepsy, Sleep and Health Research, Department of Biobehavioral Health Science, College of Nursing, USA.
James J HerdegenSleep Medicine, Rush University Medical Center, USA.

Funding

Efficacy and mechanisms of a behavioral therapy for insomnia coexisting with COPDR01NR013937 · NINR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KAPELLA, MARY C · 2013 to 2017
$2.3M
Nurse Managed Cognitive Behavioral Therapy for Insomnia in People with COPDK01NR010749 · NINR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KAPELLA, MARY C · 2008 to 2010
$287k
NINR NIH HHS K01 NR010749NINR NIH HHS R01 NR013937
6 · The paper itself

Abstract

backgroundActigraphy is commonly used to measure sleep outcomes so that sleep can be measured conveniently at home over multiple nights. Actigraphy has been validated in people with sleep disturbances; however, the validity of scoring settings in people with chronic medical illnesses such as chronic obstructive pulmonary disease remains unclear. The purpose of this secondary analysis was to compare actigraphy-customized scoring settings with polysomnography (PSG) for the measurement of sleep outcomes in people with chronic obstructive pulmonary disease who have insomnia.

methodsParticipants underwent overnight sleep assessment simultaneously by PSG and actigraphy at the University of Illinois of Chicago Sleep Science Center. Fifty participants (35 men and 15 women) with mild-to-severe chronic obstructive pulmonary disease and co-existing insomnia were included in the analysis. Sleep onset latency, total sleep time (TST), wake after sleep onset (WASO), and sleep efficiency (SE) were calculated independently from data derived from PSG and actigraphy. Actigraphy sleep outcome scores obtained at the default setting and several customized actigraphy settings were compared to the scored PSG results.

resultsAlthough no single setting was optimal for all sleep outcomes, the combination of 10 consecutive immobile minutes for sleep onset or end and an activity threshold of 10 worked well. Actigraphy overestimated TST and SE and underestimated WASO, but there was no difference in variance between PSG and actigraphy in TST and SE when the 10 × 10 combination was used. As the average TST and SE increased, the agreement between PSG and actigraphy appeared to increase, and as the average WASO decreased, the agreement between PSG and actigraphy appeared to increase.

conclusionResults support the conclusion that the default actigraphy settings may not be optimal for people with chronic obstructive pulmonary disease and co-existing insomnia.

Indexed as

ActigraphySleepCognitive Behavioral TherapyFemaleHumansMaleMiddle AgedOutcome Assessment, Health CarePolysomnographyPulmonary Disease, Chronic ObstructiveSleep Initiation and Maintenance DisordersChronic obstructive pulmonary diseaseInsomniaPolysomnographySleep disturbanceWASO

Identifiers

PMID28899522
PMCPMC5665056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.